Inventor · disambiguated record
Frank Seebach
Also filed as: SEEBACH FRANK
0 granted patents·3 pending applications·0 citations·filing 2023–2023
Files withREGENERON PHARMA3
Top patents by PatentIndex Score
3 records- 0165US2024043560A1Methods of Treating Metastatic Castration-Resistant Prostate Cancer with Bispecific Anti-PSMA x Anti-CD28 Antibodies in Combination with Anti-PD-1 AntibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0264US2025304714A1Methods of Treating Metastatic Castration-Resistant Prostate Cancer with Bispecific Anti-PSMA x Anti-CD3 Antibodies Alone or in Combination with Anti-PD-1 AntibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0363US2024270849A1Methods of treating cancer with bispecific egfr xcd28 antibodies alone or in combination with anti-pd-1 antibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Seebach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →